Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis. 2014

Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
Department of Haematology and Central Haematology Laboratory, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

BACKGROUND A clinically relevant bleeding diathesis is a frequent diagnostic challenge, which sometimes remains unexplained despite extensive investigations. The aim of our work was to evaluate the diagnostic utility of functional platelet testing by flow cytometry in this context. METHODS In case of negative results after standard laboratory workup, flow cytometric analysis (FCA) of platelet function was done. We performed analysis of surface glycoproteins Ibα, IIb, IIIa; P-selectin expression and PAC-1 binding after graded doses of ADP, collagen, and thrombin; content/secretion of dense granules; and ability to generate procoagulant platelets. RESULTS Of 437 patients investigated with standard tests between January 2007 and December 2011, we identified 67 (15.3%) with high bleeding scores and nondiagnostic standard laboratory workup including platelet aggregation studies. Among these patients, FCA revealed some potentially causative platelet defects: decreased dense granule content/secretion (n = 13); decreased α-granule secretion induced by ADP (n = 10), convulxin (n = 4), or thrombin (n = 3); decreased fibrinogen receptor activation induced by ADP (n = 11), convulxin (n = 11), or thrombin (n = 8); and decreased generation of COAT platelets, that is, highly procoagulant platelets induced by simultaneous activation with collagen and thrombin (n = 16). CONCLUSIONS Our work confirms that storage pool defects are frequent in patients with a bleeding diathesis and normal coagulation and platelet aggregations studies. Additionally, FCA is able to identify discrete platelet activation defects. In particular, we show for the first time that a relevant proportion of these patients has an isolated impaired ability to generate COAT platelets--a conceptually new defect in platelet procoagulant activity, which is missed by conventional laboratory workup.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010980 Platelet Membrane Glycoproteins Surface glycoproteins on platelets which have a key role in hemostasis and thrombosis such as platelet adhesion and aggregation. Many of these are receptors. PM-GP,Platelet Glycoprotein,Platelet Membrane Glycoprotein,PM-GPs,Platelet Glycoproteins,Glycoprotein, Platelet,Glycoprotein, Platelet Membrane,Glycoproteins, Platelet,Glycoproteins, Platelet Membrane,Membrane Glycoprotein, Platelet,Membrane Glycoproteins, Platelet,PM GP
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001791 Blood Platelet Disorders Disorders caused by abnormalities in platelet count or function. Thrombocytopathy,Blood Platelet Disorder,Disorder, Blood Platelet,Disorders, Blood Platelet,Platelet Disorder, Blood,Platelet Disorders, Blood,Thrombocytopathies
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003435 Crotalid Venoms Venoms from snakes of the subfamily Crotalinae or pit vipers, found mostly in the Americas. They include the rattlesnake, cottonmouth, fer-de-lance, bushmaster, and American copperhead. Their venoms contain nontoxic proteins, cardio-, hemo-, cyto-, and neurotoxins, and many enzymes, especially phospholipases A. Many of the toxins have been characterized. Bothrops Venom,Crotalidae Venoms,Pit Viper Venoms,Rattlesnake Venoms,Crotactin,Crotalid Venom,Crotalin,Crotaline Snake Venom,Crotalotoxin,Crotamin,Pit Viper Venom,Rattlesnake Venom,Snake Venom, Crotaline,Venom, Bothrops,Venom, Crotalid,Venom, Crotaline Snake,Venom, Pit Viper,Venom, Rattlesnake,Venoms, Crotalid,Venoms, Crotalidae,Venoms, Pit Viper,Venoms, Rattlesnake,Viper Venom, Pit
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease

Related Publications

Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
April 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
September 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
January 2000, Vox sanguinis,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
May 2002, Thrombosis research,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
August 2001, Current protocols in cytometry,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
October 2018, Research and practice in thrombosis and haemostasis,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
January 2016, Thrombosis research,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
January 1993, Haemostasis,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
August 2021, Blood advances,
Michael Daskalakis, and Giuseppe Colucci, and Peter Keller, and Sophie Rochat, and Tobias Silzle, and Franziska Demarmels Biasiutti, and Gabriela Barizzi, and Lorenzo Alberio
April 2021, Hamostaseologie,
Copied contents to your clipboard!